New cure strategies for Hepatitis B are in development. Emerging data suggests a key role for biomarkers to identify subsets of people living with Hepatitis B who are most likely to respond to treatment. In this webinar, we discussed recent advances in Hepatitis B biomarker development, and how these tools can be used to personalise the management of people living with Hepatitis B.
Is Hepatitis B entering the era of personalised medicine?
April 18, 2023
Статья
Получите подписку на последние новости и обновления LabInsights

Подпишитесь на рассылку Lab Insights и получайте последние новости и обновления

Другие материалы по этой же теме
Select a related post from the options below.
Читать далее